Patrick Van Berkel
Company: ADC Therapeutics
Job title: Senior Vice President - Resesarch & Development
Bio:
Patrick van Berkel was appointed as Senior Vice President Research & Development for ADC Therapeutics SA in August 2012 and since then he has been leading the development of ADC Therapeutics product portfolio. Before ADC Therapeutics, Patrick worked for Genmab BV, where he had various positions with increasing scientific and management responsibilities in the area of antibody engineering and antibody manufacturing. From 2001 to 2003, Patrick worked for Crucell as Senior Scientist Antibody Technology. Patrick worked from 1996 to 2001 for Pharming as scientist protein chemistry. In 1996, Patrick obtained his PhD from the University of Leiden, The Netherlands.
Seminars:
Live Discussion & Question Time 10:00 am
day: Day Two
An Overview of the Successful Development of Loncastuximab tesirine, a PBD Based ADC Directed Against CD19 for the Treatment of Hematological Malignancies 9:00 am
• Review thepreclinical data for IND approval • Gain an overview of manufacturing strategy • Analyze the clinical dataRead more
day: Day Two
An Overview of the Successful Development of Loncastuximab tesirine, a PBD Based ADC Directed Against CD19 for the Treatment of Hematological Malignancies 4:15 pm
• Review the preclinical data for IND approval • Gain an overview of manufacturing strategy • Analyze the clinical dataRead more